Annals of Clinical Microbiology, The official Journal of the Korean Society of Clinical Microbiology

6

Weeks in Review

2

Weeks to Publication
Indexed in KCI, KoreaMed, Synapse, DOAJ
Open Access, Peer Reviewed
pISSN 2288-0585 eISSN 2288-6850

Prevalence of Mycoplasma pneumoniae Antibodies in Healthy Residents of Jeonnam Province

Original article

Annals of Clinical Microbiology (Ann Clin Microbiol) 2007 October Volume 10, Issue 2, pages 109-113.


https://doi.org/10.5145/ACM.2007.10.2.109

Prevalence of Mycoplasma pneumoniae Antibodies in Healthy Residents of Jeonnam Province

Song-Mee Bae1, Mi-Jung Jang1, Hyun-Jae Song2, Doo-Young Jeon3, Sun-Seog Kweon4, Yeon-Ho Kang1
1Division of Bacterial Respiratory Infections, Center for Infectious Diseases, National Institute of Health, Korea Centers for Diseases Control and Prevention, Seoul; 2Department of Clinical Pathology, Gwangju Health College, Gwangju, 3Micobiology Division, Jeollanam-do Institute of Health and Environment, Gwangju; 4Department of Preventive Medicine, Seonam University College of Medicine, Namwon, Korea

Abstract

Background: Mycoplasma pneumoniae is the most frequent cause of respiratory tract infections in school- aged children and adolescents. For appropriate use of antibiotics, diagnosis of M. pneumoniae infection in routine clinical practice has been based on serology using a single serum sample. We evaluated the seroprevalence of anti-M. pneumoniae-specific antibodies in 500 asymptomatic, healthy persons in Jeonnam Province.

Methods: Sera were collected from 500 healthy persons in Jeonnam Province. Anti-M. pneumoniae antibody titer was measured using a microparticle agglutination assay Serodia Myco II (Fujirebio, Japan) and VIRCELL IgM Mycoplasma ELISA kits (Vircell, Granada, Spain).

Results: Anti-M. pneumoniae antibody titers in 500 healthy individuals were 1:20 in 344 (68.8%), 1:40 in 16 (3.2%), 1:80 in 71 (14.2%), 1:160 in 45 (9.0%), 1:320 in 14 (2.8%), and >1:320 in 10 (2.0%). The positive rate of M. pneumoniae IgM antibodies was 3.2% (15/473). The prevalence of IgM was 10.0% in the 7∼9 years, 9.1% in the 10∼19 years, and 5.0% in the 20∼29 years old group, which was significantly higher than that in elderly people.

Conclusion: Some of healthy people showed a high anti-M. pneumoniae antibody titer (>1:160) and positive IgM, and an assessment of current infection with single serum serology has its limitation for the diagnosis of M. pneumoniae infections. (Korean J Clin Microbiol 2007;10:109-113)

Keywords

M. pneumoniae, Seroprevalence, IgM